期刊文献+

白花丹素对舌癌细胞Tca-8113放疗增敏的作用

Plumbagin Enhanced the Radiotherapy Sensitivity of Tongue Cancer Cell Line Tca-8113
下载PDF
导出
摘要 目的:探讨白花丹素联合X-射线对舌癌细胞Tca-8113的放疗增敏作用及其机制。方法:体外培养舌癌细胞株Tca-8113,分空白对照组、单纯白花丹素组、单纯放疗组及白花丹素联合放疗组;应用MTT法检测白花丹素对舌癌Tca-8113细胞的毒性作用及最佳实验浓度;应用克隆形成确定白花丹素的放疗增敏效应;应用流式细胞仪检测各组细胞的凋亡率;采用Western Blot检测放射单独及联合白花丹素作用于Tca-8113细胞后,细胞核中NF-κB的蛋白表达水平的变化。结果:经MTT检测表明,白花丹素对舌癌Tca-8113生长抑制浓度IC10为1.42μmol/L(24h),即为最佳实验浓度;经克隆形成检测显示,白花丹素对舌癌Tca-8113细胞具有放疗增敏效应,增敏系数SER为1.28;流式细胞仪分析表明,白花丹素组与放疗组比较,其细胞早期凋亡率无明显差异,而两者联合作用后,舌癌细胞的早期凋亡率显著增高;Western Blot检测显示,白花丹素能够显著抑制放射对Tca-8113细胞核中NF-κB的激活作用。结论:白花丹素能够诱导舌癌Tca-8113凋亡并具有放疗增敏作用,抑制细胞中NF-κB的激活可能是其放射增敏的主要机制。 Objective: To study radiation sensitizing effect of Plumbagin on human tongue cancer cell line Tca-- 8113. Methods: The Tca--8113 ceils were cultured in vitro and randomized into control, radiation alone, Plumbagin alone and combination treatment group. MTT assay was employed to examine the growth status of the cells and de- termine the optimum dose for research. Clongenic assay was used to detect the survival of cells and confirm the radi ation sensitizing effect of plumbagin. The flow cytometry was applied to detect the apoptosis ratio of Tca--8113 cells in each group. Expression of nuclear factor-- kB was assessed by Western Blot. Results: The optimum dose of plumbagin on Tca--8113 ceils was 1.42μm/L for 24h. The clongenic assay suggested the enhancement of radiative sensitizion in virtue of plumbagin,SER was 1.28. Activation of NF-κB was repressed by Plumbagin. Conclusion.. Plumbagin can enhance the radiation sensitizing of human tongue cancer cell line Tca--8113. The repression of NF--κB might be the main mechanism of radiosensitivity enhancement.
出处 《口腔医学研究》 CAS CSCD 2013年第9期810-813,共4页 Journal of Oral Science Research
基金 江西省卫生厅中医药重大课题(编号:2010Z009)
关键词 舌癌细胞 白花丹素放疗增敏NF-κB Tongue cancer Plumbagin Radiosensitivity NF-κB
  • 相关文献

参考文献11

  • 1Kyoung-Ok Hong,Ji-Hong Kim,Ji-Soo Hong,et al.Inhibition of Akt activity induces the mesenchymal - to-epithelial reverting transition with restoring E-Cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells [J].J Exp Clin Cancer Res,2009,28( 1):28.
  • 2Lee SY,Park HR,Cho NH,et al.Identifying genevS related to radiation resistancein oral squamous.cell carcinoma cell lines [J].Int J Oral Maxillofac Surg,2012,321(1):18-26.
  • 3Yixue Gu,Shasha Fan.Binjie Liu,et al.TCRPl promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway [J].Mol Cell Biochem,2011,357(1-2):107-113.
  • 4Robert J,McKallip,Catherine Lombard,et al.Plumbagin-induced apoptosis in lymphocytes is mediated through increased reactive oxygen species production,upregulation of Fas* and activation of the caspase cascade [J].Toxicology and Applied Pharmacology,2010,24:741-52.
  • 5Nair S,Nair RR,Srinivas P,et al.Radiosensitizing effects of plumbagin in cervical cancer cells is through modulation of apoptotic pathway [J].Mol Carcinog,2008,47(1):22-33.
  • 6Prasad VS,Devi PU,Rao BS,et al.Radiosensitizing effect of plumbagin on mouse melanoma cells grown in vitro [J].Indian J Exp Bio,1996,34(9):857-858.
  • 7吴敬波,何芬,范娟,郎锦义.拓扑替康对鼻咽癌放射增敏的体外实验研究[J].四川医学,2004,25(9):968-970. 被引量:7
  • 8Sethi G,Sung B,Aggarwal BB.Nuclear factor-kappaB activation:from bench to bedside [J].Exp Biol Med (Maywood),2008,233(1):21-31.
  • 9Sarkar FH,Li Y,Kong D.NF-kappaB signaling pathway and its therapeutic implications in human diseases [J].Int Rev Immunol,2008,27(5):293-319.
  • 10Kozakai N,Kikuchi E,Hasegawa M,et al.Enhancement of radiosensitivity by a unique novel NF-kB inhibitor,DH-MEQ.in prostate cancer [J].Br J Cancer,2012,107(4):652-7.

二级参考文献13

  • 1Andrea Ardizzoni,Heine Hansen,Per Dombernowsky,et al.Topotecan a new active drug in the second-line treatment of small-cell lung cancer:a phase Ⅱ study in patients with refractory and sensitive disease[J].J Clin Oncol,1997,15(5):2090~2096
  • 2Giorgio Bolis,Giovanna Scarfone,Saverio Tateo,et al.Response and toxicity in sensitive ovarian cancer cases with small residual disease after first-line treatment with carboplatinum and paclitaxel[J].Gynecologic Oncology,2001,80(1):13~15
  • 3Joan H Schiller,Kyung Mann Kim,Paul Hutson,et al.Phase Ⅱ study of topotecan in patients with extensive-stage small-cell carcinoma of the lung:An eastern cooperative oncology group trial[J].J Clin Oncol,1996,14(8):2345~2352
  • 4Roseanne E Boscia,Timothy Korbut,Sylvia A Holden,et al.Interaction of topoisomerase I inhibitors with radiation in cis-Diamminedichloroplatinum(Ⅱ)-sensitive and-resistant cells in vitro and in the FSAⅡC fibrosarcoma in vivo[J].Int J Cancer,1993,53:118~
  • 5Maria C Bell,Susan A Davidson,J Michael Mathis,et al.Topotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma:a phase I trial[J].Gynecologic Oncology,2001,80(2):128-131
  • 6Eric K,Rowinsky,Louise et al.Phase I and pharmacologic study of topotecan:a novel topoisomerase I inhibitor[J].J Clin Oncol,1992,10(4):647-656
  • 7Christophe Hennequin,Nicol Giocanti,Jacques Balosso,et al.Interaction of ionizing Radiation with the Topoisomerase I poison camptothecin in growing V-79 and heLa cells[J].Cancer Res,1994,54:1720-1728
  • 8Renato Marchesini,Ambrogio Colombo,Claudia Caserini,et al.Interaction of ionizing radiation with topotecan in two human tumor cell lines[J].Int.J Cancer,1996,66:342-346
  • 9Joanchim Von Pawel,Joan H Schiller,Frances A Shepherd,et al.Topotecan versus cyclophosphamide,doxorubicin,and vincristine for the treatment of recurrent small-cell lung cancer[J].J Clin Oncol,1999,17(2):658-667
  • 10Bruce NG,Elissa Kramer,Leonard Liebes,et al.Radiosensitization of tumor-targeted radioimmuno with prologed topotecan infusion in human breast cancer xenografts[J].Cancer Res,2001,61:2996-3001

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部